126 related articles for article (PubMed ID: 15828025)
1. Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.
Russo A; Corsale S; Cammareri P; Agnese V; Cascio S; Di Fede G; Macaluso M; Bazan V
J Cell Physiol; 2005 Sep; 204(3):742-9. PubMed ID: 15828025
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of colorectal cancer prevention and treatment.
Nguyen H; Tran A; Lipkin S; Fruehauf JP
Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics in chemotherapy of colorectal cancer.
Henriette Tanja L; Guchelaar HJ; Gelderblom H
Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.
Kweekel DM; Gelderblom H; Guchelaar HJ
Cancer Treat Rev; 2005 Apr; 31(2):90-105. PubMed ID: 15847979
[TBL] [Abstract][Full Text] [Related]
5. Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development.
Lee W; Lockhart AC; Kim RB; Rothenberg ML
Oncologist; 2005 Feb; 10(2):104-11. PubMed ID: 15709212
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
Milano G
Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics and -genetics in colorectal cancer.
Pohl A; Lurje G; Manegold PC; Lenz HJ
Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
Hasegawa Y
Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
Marcuello E; Altés A; Menoyo A; Rio ED; Baiget M
Cancer Chemother Pharmacol; 2006 Jun; 57(6):835-40. PubMed ID: 16187112
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics/genomics and personalized medicine.
Sadée W; Dai Z
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy.
Ruzzo A; Graziano F; Loupakis F; Rulli E; Canestrari E; Santini D; Catalano V; Ficarelli R; Maltese P; Bisonni R; Masi G; Schiavon G; Giordani P; Giustini L; Falcone A; Tonini G; Silva R; Mattioli R; Floriani I; Magnani M
J Clin Oncol; 2007 Apr; 25(10):1247-54. PubMed ID: 17401013
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic markers of toxicity for chemotherapy in colorectal cancer patients.
Cortejoso L; López-Fernández LA
Pharmacogenomics; 2012 Jul; 13(10):1173-91. PubMed ID: 22909207
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetics and pharmacogenomics of cancers].
Robert J
Pathol Biol (Paris); 2004 Jul; 52(6):332-7. PubMed ID: 15261376
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics in gastrointestinal tumors.
Stöhlmacher J
Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
[TBL] [Abstract][Full Text] [Related]
15. Molecular markers of chemotherapeutic response and toxicity in colorectal cancer.
Braun MS; Quirke P; Seymour MT
Expert Rev Anticancer Ther; 2007 Apr; 7(4):489-501. PubMed ID: 17428170
[TBL] [Abstract][Full Text] [Related]
16. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the pharmacogenetics of cancer chemotherapy.
Watters JW; McLeod HL
Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
[TBL] [Abstract][Full Text] [Related]
18. Applications of genomic tools to colorectal cancer therapeutics.
Auman JT; McLeod HL
Curr Opin Mol Ther; 2008 Dec; 10(6):548-54. PubMed ID: 19051132
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in gastrointestinal disorders.
Camilleri M; Saito YA
Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics and biomarkers in colorectal cancer.
Strimpakos AS; Syrigos KN; Saif MW
Pharmacogenomics J; 2009 Jun; 9(3):147-60. PubMed ID: 19381163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
